Inovo, a venture capital firm investing in technology startups across Poland and Central & Eastern European region (CEE), has today announced the final close of its second fund, Inovo II, at EUR54 million
Inovo specialises in identifying disruptive tech startups and supporting their development and growth through participation in early-stage, post-traction seed and Series A funding. Having a diverse range of LPs in the fund will enable portfolio companies to secure global funding as they scale and expand abroad. The new fund has already committed funding to several investment opportunities with leading international investors, including European Bank for Reconstruction and Development (EBRD), Andreessen Horowitz, Hoxton Ventures and Point Nine Capital. Notable investments include: Spacelift, Infermedica, Jutro Medical, AI Clearing, Zowie, Preply, Packhelp, Intiaro, Tidio, Allset and Eyerim.
This fundraise follows the success of Inovo I which generated 3.2x return on investments from a portfolio of 15 high-growth tech startups, most of which have since been sold profitably, two have IPO’d, and three top-performing remain in the portfolio.
